Keenova Therapeutics plc

MNKTQDelisted Sep 6, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001567892

SEC filings (opens in a new tab)

Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Nov 9, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.

Key figures

Market cap: –; Not available
Insider buys: 3; Last 90 days, $80.9M in total
Insider sells: 0; Open market, last 90 days
13F holders: 36; Q2 2023, −9 vs. previous quarter
13F value: $12.4M; Reported value at the end of Q2 2023
Superinvestors holding: 0; At the end of Q2 2023

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $1.43B; −27.7% year over year
Net income, FY2025: -$489.5M; −202.4% year over year
Free cash flow, FY2025: –; No comparable prior period
Revenue, Q3 FY2026: $549.5M; −27.0% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $489.5M (34.2% of revenue).

Superinvestors holding MNKTQ, Q2 2023

Go to the superinvestors tab

No superinvestor reported holding MNKTQ at the end of Q2 2023.

Latest insider trades

See all insider trades

Open-market purchases and sales by Keenova Therapeutics plc insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 9, 2026 (view filing)5:30 PM ET	Nov 5-6	4 days	Goldentree Asset Management LP and 2 others10% Owner	PPurchase	+295.7K	$89.25	+$26.4M	+3.4%8.88M after	2 lots
Oct 16, 2026 (view filing)4:30 PM ET	Oct 14	2 days	Goldentree Asset Management LP and 2 others10% Owner	PPurchase	+137.0K	$90.00	+$12.3M	+1.6%8.58M after
Oct 6, 2026 (view filing)4:30 PM ET	Sep 24	12 daysLate	Goldentree Asset Management LP and 2 others10% Owner	PPurchase	+463.0K	$91.00	+$42.1M	+5.8%8.44M after
May 21, 2026 (view filing)8:59 PM ET	May 19-20	2 days	Mule Edward A and 2 others10% Owner	PPurchase	+397.5K	$90.50	+$36.0M	+7.1%6.04M after	2 lots
Apr 17, 2026 (view filing)5:23 PM ET	Apr 15-17	2 days	Mule Edward A and 2 others10% Owner	PPurchase	+685.0K	$89.70	+$61.4M	+13.8%5.64M after	2 lots
Jan 9, 2026 (view filing)5:26 PM ET	Jan 7	2 days	Mule Edward A and 2 others10% Owner	PPurchase	+250.0K	$92.25	+$23.1M	+5.3%4.95M after
Dec 10, 2025 (view filing)6:14 PM ET	Dec 8	2 days	Mule Edward A and 2 others10% Owner	PPurchase	+131.0K	$88.75	+$11.6M	+2.9%4.70M after
Nov 19, 2025 (view filing)6:39 PM ET	Nov 17-19	2 days	Mule Edward A and 2 others10% Owner	PPurchase	+68.0K	$88.88	+$6.04M	+1.5%4.57M after	2 lots
Nov 12, 2025 (view filing)8:16 PM ET	Nov 10	2 days	Mule Edward A and 2 others10% Owner	PPurchase	+290.0K	$93.75	+$27.2M	+6.9%4.50M after
Aug 6, 2025 (view filing)7:45 PM ET	Aug 4-6	2 days	Goldentree Asset Management LP and 2 others10% Owner	PPurchase	+36.7K	$88.21	+$3.24M	+0.5%7.95M after	2 lots

Top 10 13F holders, Q2 2023

See all 36 holders

The largest institutional positions in Keenova Therapeutics plc at the end of Q2 2023; share changes are against Q1 2023.

Institutions holding MNKTQ in Q2 2023
Institution	Shares	Value	% of portfolio	Change in shares	Action
Bracebridge Capital, LLC	2,033,257	$2.40M	1.91%	00.0%	Unchanged
Alta Fundamental Advisers LLC	1,947,093	$2.30M	1.26%	+1,215,000+166.0%	Added
JPMorgan Chase & Co	1,316,260	$1.55M	0.00%	−365,378−21.7%	Reduced
Hudson Bay Capital Management LP	1,041,560	$1.23M	0.01%	−100,000−8.8%	Reduced
Continental General Insurance Co	880,822	$1.04M	0.37%	+781,154+783.8%	Added
Sculptor Capital LP	694,649	$819.7K	0.02%	00.0%	Unchanged
Vanguard Group Inc	644,153	$760.1K	0.00%	00.0%	Unchanged
Two Seas Capital LP	585,602	$691.0K	0.15%	+568,346+3,293.6%	Added
BlackRock Inc.	203,658	$240.3K	0.00%	+11,351+5.9%	Added
Bank of America Corp	156,282	$184.4K	0.00%	−600.0%	Reduced

Holders of 5% or more of MNKTQ

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Keenova Therapeutics plc.

Largest holders of MNKTQ from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Goldentree Asset Management LP	13D/A	22.40%8.88M shares	+1.10 ppfrom 21.30%	Dec 13, 20235 filings	Nov 10, 2026	SEC
Silver Point Capital L.P.	13D/A	15.20%6.04M shares	+1.00 ppfrom 14.20%	Nov 24, 20238 filings	May 22, 2026	SEC
Marathon Asset Management LP	13G/A	6.80%2.71M shares	−0.90 ppfrom 7.70%	Feb 6, 20244 filings	May 15, 2026	SEC
Hein Park Capital Management LP	13G	5.50%2.15M shares	+0.60 ppfrom 4.90%	Jan 17, 20247 filings	Feb 13, 2026	SEC
Hudson Bay Capital Management LP	13G/A	5.19%2.05M shares	−1.11 ppfrom 6.30%	Feb 9, 20235 filings	Feb 11, 2026	SEC